Overview
Overview
Parent Cell: Akira Epidermal Skin Cells differentiated from UCT-WJ-MSCs | Skin-specific regenerative exosomes for wound healing, scar remodeling, aesthetic skin rejuvenation, and chronic skin conditions
FOR RESEARCH USE AND INTERNATIONAL USE ONLY
| Source & Manufacturing |
|---|
| 110 Billion Exosomes / 1 mL vial |
| EGF, VEGF confirmed by ELISA |
| miR-21 / TGF-β inhibitors confirmed by qPCR |
| NTA mean size 80–115 nm |
| Stored at −80°C |
Definition
What Are Exosomes?
Exosomes are nanoscale extracellular vesicles (40–150 nm) formed by inward budding of endosomal multivesicular bodies (MVBs) and released upon MVB fusion with the plasma membrane. They carry a protected cargo of mRNAs, miRNAs, proteins, lipids, and signaling molecules from their parent cell, delivering this molecular payload to recipient cells with high specificity and efficiency. Unlike the parent cell, exosomes carry no nuclear material and cannot self-replicate — providing a cell-free therapeutic profile with superior safety and stability characteristics.
Process
Mechanism of Action & Molecular Cargo
Re-Epithelialization Acceleration: EGF, KGF (FGF-7), and TGF-α cargo activates keratinocyte EGFR, driving migration and proliferation for wound closure — demonstrated by 45% faster re-epithelialization in full-thickness wound models.
Collagen Remodeling: TGF-β inhibitor miRNAs (miR-21) combined with EGF-driven fibroblast stimulation achieve optimal collagen I:III ratio — reducing hypertrophic scarring while maintaining wound strength.
Angiogenesis: VEGF-A delivery to wound bed promotes capillary ingrowth, essential for dermal matrix remodeling and wound tissue oxygenation.
Anti-Inflammatory: miR-146a suppresses macrophage M1 activation, reducing chronic wound inflammation that impairs healing in diabetic ulcers and chronic wounds.
Anti-Hyperpigmentation: Melanocyte-suppressing KGF/SCF balance modulation reduces post-inflammatory hyperpigmentation and normalizes melanin distribution.
Biomarkers
Key Molecular Cargo
| Molecule / miRNA | Therapeutic Function |
|---|---|
| EGF / KGF (FGF-7) | Keratinocyte migration and proliferation; re-epithelialization |
| VEGF-A | Wound bed angiogenesis |
| miR-21 | TGF-β suppression → anti-fibrotic; hypertrophic scar prevention |
| miR-146a | Anti-inflammatory; M1 macrophage suppression in wound bed |
| SCF / KGF (melanocyte modulation) | Hyperpigmentation correction via melanocyte activity normalization |
| Collagen I/III mRNA induction | Fibroblast collagen quality optimization |
Applications
Therapeutic Applications
- Burns & Scalds — accelerated re-epithelialization
- Diabetic Ulcers — chronic wound closure
- Acne Scars — collagen remodeling, texture improvement
- Hyperpigmentation — melanocyte normalization
- Wrinkle Reduction / Skin Aging — collagen and elastin stimulation
- Post-Microneedling / Post-Laser Recovery — enhanced healing
- Stretch Marks (Striae) — dermal matrix regeneration
- Lichen Sclerosus — anti-inflammatory, tissue restoration
- Psoriasis — keratinocyte proliferation normalization
Evidence
Clinical & Preclinical Evidence
A 2025 systematic review (PMC12736761) of MSC-exosome-based dermatological treatments (10 human studies) confirmed significant scar remodeling, pigmentation improvement, and skin quality enhancement — with excellent safety and no adverse events across all indications.[1]
A 2024 study in Signal Transduction and Targeted Therapy (Nature Portfolio journal) confirmed MSC-derived EVs improve tissue remodeling, fibroblast function, and dermal repair in aging skin — directly supporting Akira Skin Exosome mechanisms.[2]
A retrospective case series (June 2023–November 2024) using stem cell-derived exosomes in dermatological wound healing and scar management showed significant scar improvement, enhanced elasticity, and improved hydration across all 4 cases at follow-up up to 10 months.[3]
Multiple systematic reviews of MSC exosome skin wound healing confirm consistent anti-inflammatory, pro-angiogenic, and matrix-remodeling effects across wound types — establishing the mechanistic evidence base for Akira Skin Exosomes.[2][4]